- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04926389
Two Low-level Laser Irradiation Protocols on the Rate of Canine Retraction
The Effect of Two Low-level Laser Irradiation Protocols on the Rate of Canine Retraction (a Randomized Controlled Clinical Trial)
Descripción general del estudio
Estado
Condiciones
Descripción detallada
A randomized controlled clinical trial will be conducted to address the aim of the study. Sixteen patients will be recruited, requiring the therapeutic extraction of the maxillary 1st premolars, with subsequent canine retraction into the extraction space. The sample will be randomly divided into 2 equal groups, each including 8 subjects.
In Group A, one side of the maxillary arch will randomly receive LLLT on days 0, 3, 7, 14, and every 2 weeks thereafter, while in Group B, one side will also be randomly chosen to receive LLLT every 3 weeks. The contralateral sides of both groups will serve as the controls. The LLLT applied will be Diode laser emitting infrared radiation at wavelength of 980 nm, in a continuous mode.
Canine retraction in both groups will be carried out bilaterally using nickel-titanium closed-coil spring, delivering 150 grams of force, and the rate of tooth movement will be checked every 3 weeks, over a period of 3 months. Other variables will be also examined including, interleukin-1β level in the gingival crevicular fluid, root resorption, and molar anchorage loss.
Tipo de estudio
Inscripción (Anticipado)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Alexandria, Egipto
- Alexandria Faculty of Dentistry
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Malocclusion requires at least the extraction of maxillary first premolars, followed by canine retraction into the extraction site.
- Normal shape and structure of the maxillary canines, with no history of root canal treatment.
- Patients with good oral hygiene, and a healthy periodontal condition.
Exclusion Criteria:
- Patients who underwent previous orthodontic treatment.
- Patients currently receiving drug therapy that may affect orthodontic tooth movement, e.g. hormonal therapy and corticosteroids.
- Patients with chronic diseases that may affect the rate of tooth movement.
- Pregnancy and lactation
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: low-level laser therapy applied on days 0, 3,7,14 & every 2 weeks
|
one side of the maxillary arch will randomly receive LLLT on days 0, 3, 7, 14, and every 2 weeks thereafter and the contralateral side will serve as the controls.
|
|
Comparador activo: low-level laser therapy applied every 3 weeks
|
one side will also be randomly chosen to receive LLLT every 3 weeks and the contralateral side will serve as the controls.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in rate of canine retraction
Periodo de tiempo: at baseline and every 3 weeks for 3 months
|
Several landmarks will be identified on the dental cast, including the mid-palatal raphe, the most medial points on the third right and left rugae, and the cusp tips of the right and left maxillary canines.
Perpendicular lines will be drawn from the medial points of the right and left third rugae, and the cusp tips of the right and left maxillary canines to the mid-palatal raphe.
The antero-posterior measurements will be carried out between the canine lines and the third rugae lines bilaterally, to assess the rate of canine retraction.
|
at baseline and every 3 weeks for 3 months
|
|
change in IL-1β level in the Ginigval Crevicular Fluid
Periodo de tiempo: at baseline, 7th, 17th and 21st day
|
Samples from the GCF will be collected at baseline (before the first canine retraction), in addition to days 7, 14, and 21.
GCF samples will be collected from the distal crevices of the canines, in Groups A and B, on both the experimental and control sides.
Measurement of IL-1β level in the GCF will be performed using an ELISA kit.
|
at baseline, 7th, 17th and 21st day
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
change canine root resorption:
Periodo de tiempo: at baseline and 3 months
|
Root resorption of the maxillary canines will be evaluated and measured on the acquired pre-retraction and post-retraction CBCT scans.
|
at baseline and 3 months
|
|
Change molar anchorage loss
Periodo de tiempo: at baseline and every 3 weeks for 3 months
|
Perpendicular lines will be drawn from the central fossae of both maxillary right and left first molars to the mid-palatal raphe.
Consequently, molar anchorage loss will be calculated by measuring the distance between those lines, and the lines representing the third rugae as previously mentioned.
|
at baseline and every 3 weeks for 3 months
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- Canine retraction 2020
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .